RARITAN, N.J., Aug. 28, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that ORTHO™ Sera blood grouping reagents designed for extended ...
ORTHO Sera ID-MTS Antigen Phenotyping Cleared on ORTHO VISION® Platforms in United States and Canada
RARITAN, N.J., March 10, 2020 /PRNewswire-PRWeb/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, ...
FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results